PD-L1 and BCL2 proteins ubiquitously expressed in colorectal carcinoma, suggesting prognostic biomarker roles
Evaluation of Programmed Death Ligand-1 (PD-L1) and B-cell Lymphoma 2 (BCL2) protein expression using immunohistochemistry in colorectal carcinoma patients from Anbar Governorate.
Abstract
Immunohistochemistry revealed ubiquitous expression of PD-L1 and BCL2 proteins in 60 colorectal carcinoma patients, highlighting their potential as prognostic biomarkers.
